Structure of glycosylated and unglycosylated gag and gag-pol precursor proteins of Moloney murine leukemia virus. 1983

C J Saris, and J van Eenbergen, and R M Liskamp, and H P Bloemers

Precursor polyproteins containing translational products of the gag gene of Moloney murine leukemia virus were purified by gel electrophoresis and cleaved into large fragments by hydroxylamine, mild acid hydrolysis, or cyanogen bromide. The hydroxylamine cleavage method (specific for asparagine-glycine bonds) was adapted especially for this study. The electrophoretic mobility and antigenicity of the fragments and, in some cases, the presence or absence of [35S]methionine revealed detailed information on the structure of Pr65gag, gPr80gag, and Pr75gag (the unglycosylated variant of gPr80gag formed in vivo in the presence of tunicamycin or in vitro in a reticulocyte cell-free system). When compared with Pr65gag, gPr80gag contains 7,000 daltons of additional amino acids, presumably as, or as part of, a leader sequence at or very close to its N terminus. We present evidence that this leader may have replaced part of the p15 sequence. Furthermore, gPr80gag contains three separate carbohydrate groups. One is attached to the presumed leader sequence or to the p15 domain, and two are attached to the p30 domain. Each of the Moloney murine leukemia virus gag precursor proteins Pr65gag, gPr80gag, and Pr75gag corresponds with a read-through product into the pol gene. We designated these products Pr180gag-pol, gPr200gag-pol, and Pr190gag-pol (the unglycosylated variant of gPr200gag-pol), respectively. gPr200gag-pol contains all of the extra amino acids and carbohydrate groups present in gPr80gag and at least one carbohydrate group in its pol sequences.

UI MeSH Term Description Entries
D008979 Moloney murine leukemia virus A strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) arising during the propagation of S37 mouse sarcoma, and causing lymphoid leukemia in mice. It also infects rats and newborn hamsters. It is apparently transmitted to embryos in utero and to newborns through mother's milk. Moloney Leukemia Virus,Leukemia Virus, Moloney,Virus, Moloney Leukemia
D011498 Protein Precursors Precursors, Protein
D002241 Carbohydrates A class of organic compounds composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n. The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES. Carbohydrate
D003488 Cyanogen Bromide Cyanogen bromide (CNBr). A compound used in molecular biology to digest some proteins and as a coupling reagent for phosphoroamidate or pyrophosphate internucleotide bonds in DNA duplexes. Bromide, Cyanogen
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D006898 Hydroxylamines Organic compounds that contain the (-NH2OH) radical.
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D014415 Tunicamycin An N-acetylglycosamine containing antiviral antibiotic obtained from Streptomyces lysosuperificus. It is also active against some bacteria and fungi, because it inhibits the glucosylation of proteins. Tunicamycin is used as tool in the study of microbial biosynthetic mechanisms.
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral

Related Publications

C J Saris, and J van Eenbergen, and R M Liskamp, and H P Bloemers
July 1980, Journal of virology,
C J Saris, and J van Eenbergen, and R M Liskamp, and H P Bloemers
May 1979, Journal of virology,
C J Saris, and J van Eenbergen, and R M Liskamp, and H P Bloemers
May 1981, Journal of virology,
C J Saris, and J van Eenbergen, and R M Liskamp, and H P Bloemers
July 2014, Journal of virology,
C J Saris, and J van Eenbergen, and R M Liskamp, and H P Bloemers
October 1994, Journal of biomedical science,
C J Saris, and J van Eenbergen, and R M Liskamp, and H P Bloemers
November 1991, Journal of virology,
C J Saris, and J van Eenbergen, and R M Liskamp, and H P Bloemers
November 1990, Journal of virology,
C J Saris, and J van Eenbergen, and R M Liskamp, and H P Bloemers
November 1992, Journal of virology,
C J Saris, and J van Eenbergen, and R M Liskamp, and H P Bloemers
December 1996, The Journal of cell biology,
C J Saris, and J van Eenbergen, and R M Liskamp, and H P Bloemers
October 1983, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!